MSP Recovery (NASDAQ:MSPR – Get Free Report) announced its earnings results on Wednesday. The company reported ($132.71) earnings per share for the quarter, Zacks reports. MSP Recovery had a negative net margin of 4,375.62% and a negative return on equity of 326.80%.
MSP Recovery Stock Performance
NASDAQ MSPR traded down $0.04 on Wednesday, reaching $0.45. 1,639,562 shares of the stock traded hands, compared to its average volume of 8,158,370. MSP Recovery has a 12 month low of $0.20 and a 12 month high of $28.84. The company has a market cap of $634,500.00, a price-to-earnings ratio of 0.00 and a beta of -2.58. The company has a fifty day moving average price of $0.98 and a 200-day moving average price of $5.47.
Institutional Trading of MSP Recovery
A hedge fund recently bought a new stake in MSP Recovery stock. Corient Private Wealth LLC acquired a new position in MSP Recovery, Inc. (NASDAQ:MSPR – Free Report) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 97,924 shares of the company’s stock, valued at approximately $136,000. Corient Private Wealth LLC owned 1.19% of MSP Recovery at the end of the most recent reporting period. Institutional investors and hedge funds own 3.77% of the company’s stock.
Analysts Set New Price Targets
Get Our Latest Research Report on MSP Recovery
MSP Recovery Company Profile
MSP Recovery, Inc engages in the development of healthcare recoveries and data analytics software. It also focuses on the identification and recoveries of improper payments made by Medicare, Medicaid, and commercial insurance spaces using data and analytics. The company was founded by John H. Ruiz, Frank C.
Read More
- Five stocks we like better than MSP Recovery
- What is a Microcap Stock? Everything You Need to Know
- HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?
- CD Calculator: Certificate of Deposit Calculator
- End the Year Strong With These 3 Comeback Champions
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Down 45% Year-to-Date, Novo Nordisk Ignites a Price War
Receive News & Ratings for MSP Recovery Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MSP Recovery and related companies with MarketBeat.com's FREE daily email newsletter.
